# Artia Global Partners LP: Form 13F holdings

An institutional investment manager in MIAMI, FL. SEC CIK 1937964.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $541.9m
- Positions: 48 (48 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1937964/000193796426000008/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ABIVAX SA (ABVX)](/companies/abvx.md) | SPONSORED ADS | $68.8m | 12.7% | 516,447 |  | Reduced −84,300 |
| [INSMED INC (INSM)](/companies/insm.md) | COM PAR $.01 | $62.8m | 11.6% | 589,052 |  | Reduced −39,660 |
| [TREVI THERAPEUTICS INC (TRVI)](/companies/trvi.md) | COM | $41.2m | 7.6% | 2,210,852 |  | Added +197,250 |
| [BRIGHTSPRING HEALTH SVCS INC (BTSG)](/companies/btsg.md) | COM | $36.1m | 6.7% | 517,315 |  | Added +463,515 |
| [REVOLUTION MEDICINES INC (RVMD)](/companies/rvmd.md) | COM | $34.7m | 6.4% | 185,390 |  | Added +60,400 |
| [ARGENX SE (ARGX)](/companies/argx.md) | SPONSORED ADR | $27.6m | 5.1% | 29,739 |  | Unchanged |
| ALKERMES PLC | SHS | $23.5m | 4.3% | 448,964 |  | New +448,964 |
| [TRAVERE THERAPEUTICS INC (TVTX)](/companies/tvtx.md) | COM | $19.3m | 3.6% | 339,033 |  | Added +268,333 |
| ASTRAZENECA PLC | ORD | $18.7m | 3.4% | 98,376 |  | Added +3,000 |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | $17.1m | 3.2% | 503,936 |  | Unchanged |
| [DIANTHUS THERAPEUTICS INC (DNTH)](/companies/dnth.md) | COM | $15.9m | 2.9% | 162,990 |  | Unchanged |
| SPDR SERIES TRUST | ST STR SP BIOT | $15.8m | 2.9% | 100,000 | Put | New +100,000 |
| [QUEST DIAGNOSTICS INC (DGX)](/companies/dgx.md) | COM | $13.8m | 2.5% | 65,122 |  | Added +24,305 |
| [IONIS PHARMACEUTICALS INC (IONS)](/companies/ions.md) | COM | $11.4m | 2.1% | 144,376 |  | Unchanged |
| [EYEPOINT INC (EYPT)](/companies/eypt.md) | COM NEW | $11.0m | 2.0% | 767,098 |  | Unchanged |
| [ALUMIS INC (ALMS)](/companies/alms.md) | COM | $7.8m | 1.4% | 278,546 |  | Reduced −46,500 |
| [VIKING THERAPEUTICS INC (VKTX)](/companies/vktx.md) | COM | $7.1m | 1.3% | 180,731 |  | Unchanged |
| [CELCUITY INC (CELC)](/companies/celc.md) | COM | $6.2m | 1.1% | 59,316 |  | Added +43,740 |
| [CYTOKINETICS INC (CYTK)](/companies/cytk.md) | COM NEW | $6.0m | 1.1% | 70,700 |  | Added +54,400 |
| [MERCK & CO INC (MRK)](/companies/mrk.md) | COM | $6.0m | 1.1% | 46,700 |  | Unchanged |
| [RAPPORT THERAPEUTICS INC (RAPP)](/companies/rapp.md) | COM | $5.8m | 1.1% | 138,508 |  | Unchanged |
| [JOHNSON & JOHNSON (JNJ)](/companies/jnj.md) | COM | $5.7m | 1.1% | 22,600 |  | Unchanged |
| [GUARDANT HEALTH INC (GH)](/companies/gh.md) | COM | $5.7m | 1.1% | 38,100 |  | New +38,100 |
| [ABSCI CORPORATION (ABSI)](/companies/absi.md) | COM | $5.4m | 1.0% | 464,444 |  | New +464,444 |
| [SCHOLAR ROCK HLDG CORP (SRRK)](/companies/srrk.md) | COM | $5.3m | 1.0% | 96,285 |  | Unchanged |
| [SIONNA THERAPEUTICS INC (SION)](/companies/sion.md) | COM | $5.3m | 1.0% | 119,741 |  | Unchanged |
| ASCENDIS PHARMA A/S | ORD SHS | $4.7m | 0.9% | 17,740 |  | New +17,740 |
| ROIVANT SCIENCES LTD | SHS | $4.6m | 0.8% | 129,800 |  | Unchanged |
| [PALISADE BIO INC (PALI)](/companies/pali.md) | COM | $4.2m | 0.8% | 1,992,367 |  | Unchanged |
| [EDGEWISE THERAPEUTICS INC (EWTX)](/companies/ewtx.md) | COM | $4.0m | 0.7% | 98,800 |  | Added +33,300 |
| [BIOGEN INC (BIIB)](/companies/biib.md) | COM | $4.0m | 0.7% | 18,437 |  | Unchanged |
| [XENON PHARMACEUTICALS INC (XENE)](/companies/xene.md) | COM | $3.9m | 0.7% | 65,000 |  | Unchanged |
| [BELITE BIO INC (BLTE)](/companies/blte.md) | SPONSORED ADS | $3.8m | 0.7% | 24,989 |  | Unchanged |
| [MINERALYS THERAPEUTICS INC (MLYS)](/companies/mlys.md) | COM | $3.7m | 0.7% | 137,800 |  | Unchanged |
| [PROKIDNEY CORP (PROK)](/companies/prok.md) | SHS CL A | $3.7m | 0.7% | 1,806,939 |  | Unchanged |
| [ENLIVEN THERAPEUTICS INC (ELVN)](/companies/elvn.md) | COM | $3.7m | 0.7% | 72,100 |  | Added +51,200 |
| [ORUKA THERAPEUTICS INC (ORKA)](/companies/orka.md) | COM | $3.2m | 0.6% | 33,400 |  | New +33,400 |
| [PROTAGONIST THERAPEUTICS INC (PTGX)](/companies/ptgx.md) | COM | $2.8m | 0.5% | 22,951 |  | Added +20 |
| [UNITED THERAPEUTICS CORP DEL (UTHR)](/companies/uthr.md) | COM | $2.7m | 0.5% | 5,000 |  | Unchanged |
| [BRIGHT MINDS BIOSCIENCES INC (DRUG)](/companies/drug.md) | COM NEW | $2.7m | 0.5% | 38,407 |  | Unchanged |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | $1.9m | 0.3% | 29,200 |  | Unchanged |
| [COMPASS THERAPEUTICS INC (CMPX)](/companies/cmpx.md) | COM | $839.2k | 0.2% | 383,200 |  | New +383,200 |
| [PRAXIS PRECISION MEDICINES I (PRAX)](/companies/prax.md) | COM NEW | $837.0k | 0.2% | 2,500 |  | Unchanged |
| [KODIAK SCIENCES INC (KOD)](/companies/kod.md) | COM | $663.1k | 0.1% | 17,019 |  | Unchanged |
| [TENAX THERAPEUTICS INC (TENX)](/companies/tenx.md) | COM NEW | $612.3k | 0.1% | 42,080 |  | Unchanged |
| NUVALENT INC | COM | $605.1k | 0.1% | 4,900 |  | Unchanged |
| [PEPGEN INC (PEPG)](/companies/pepg.md) | COM | $369.6k | <0.1% | 205,324 |  | Unchanged |
| [SPYRE THERAPEUTICS INC (SYRE)](/companies/syre.md) | COM NEW | $355.1k | <0.1% | 4,000 |  | New +4,000 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [ABBVIE INC (ABBV)](/companies/abbv.md) | COM | $0 | 0.0% | 0 |  | Sold out −14,500 |
| APOGEE THERAPEUTICS INC | COM | $0 | 0.0% | 0 |  | Sold out −5,886 |
| ASCENDIS PHARMA A/S | SPONSORED ADR | $0 | 0.0% | 0 |  | Sold out −17,740 |
| [AVALO THERAPEUTICS INC (AVTX)](/companies/avtx.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −28,970 |
| [BRIDGEBIO PHARMA INC (BBIO)](/companies/bbio.md) | COM | $0 | 0.0% | 0 |  | Sold out −20,400 |
| [ELI LILLY & CO (LLY)](/companies/lly.md) | COM | $0 | 0.0% | 0 |  | Sold out −38,220 |
| [INSMED INC (INSM)](/companies/insm.md) | COM PAR $.01 | $0 | 0.0% | 0 | Put | Sold out −279,700 |
| [MODERNA INC (MRNA)](/companies/mrna.md) | COM | $0 | 0.0% | 0 | Call | Sold out −200,000 |
| SOLENO THERAPEUTICS INC | COM | $0 | 0.0% | 0 |  | Sold out −68,490 |
| TERNS PHARMACEUTICALS INC | COM | $0 | 0.0% | 0 |  | Sold out −104,800 |

Source: SEC EDGAR, Form 13F-HR, accession 0001937964-26-000008. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.